CD8+ T cells in the cancer-immunity cycle is a research paper published in Immunity (2023). On theSindex it has a DataRank of 0. It has been cited 410 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Parker Institute for Cancer Immunotherapy
Grant: R01 CA230275
Parker Institute for Cancer Immunotherapy
Grant: P01 AG073084
NIH
Grant: T32 CA009140
NIH
Grant: AI108545
NIH
Grant: AI149680
NIH
Grant: HL143613
NIH
Grant: AI155577
NIH
Grant: AI082630
NIH
Grant: AI105343
Deutsche Forschungsgemeinschaft
Grant: GL 991/1-1
NCI NIH HHS
Grant: P30 CA014195
NIAID NIH HHS
Grant: U19 AI082630
NIAID NIH HHS
Grant: R01 AI155577
NIAID NIH HHS
Grant: U19 AI149680
NIAID NIH HHS
Grant: R01 AI105343
NIAID NIH HHS
Grant: P01 AI108545
NCI NIH HHS
Grant: P30 CA016520
NHLBI NIH HHS
Grant: R38 HL143613
Pfizer
Cancer Research Institute
NOMIS Foundation
The Mark Foundation for Cancer Research
FWCI
48.10
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals